Xcelerate Inc. (XCRT)
OTCMKTS · Delayed Price · Currency is USD
0.0159
0.00 (-0.06%)
Sep 19, 2025, 10:25 AM EDT
Xcelerate Market Cap
Xcelerate has a market cap or net worth of $6.89 million as of September 22, 2025. Its market cap has decreased by -60.33% in one year.
Market Cap
6.89M
Enterprise Value
8.38M
Revenue
2.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since January 25, 2005, Xcelerate's market cap has decreased from 22.60M to 6.89M, a decrease of -69.49%. That is a compound annual growth rate of -5.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 6.89M | -27.37% |
| Dec 31, 2024 | 9.49M | -39.27% |
| Dec 29, 2023 | 15.63M | 17.08% |
| Dec 30, 2022 | 13.35M | -56.33% |
| Dec 31, 2021 | 30.57M | 156.06% |
| Dec 31, 2020 | 11.94M | 4,707.39% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 791.41M |
| Tian'an Technology Group | 728.29M |
| Elite Pharmaceuticals | 667.60M |
| Glass House Brands | 551.67M |
| Northwest Biotherapeutics | 376.65M |
| Nika Pharmaceuticals | 370.64M |
| CytoDyn | 367.01M |
| American Oncology Network | 347.09M |